News & Analysis on Clinical Trial Services & Contract Research And Development
Botanical drug specialists, Phytomedics, has licensed a novel anti-inflammatory compound, achieving development of heterogenous plant-derived products as ethical drugs in the US, while reducing costs and time frames in comparison to new chemical...
Emergent Biosolutions has announced it has acquired Microscience, in a deal that adds proprietary platform technology in oral vaccine delivery. The deal also adds to Emergent's European presence in the growing global vaccine market.
NMT Medical announced that the company has received approvals to initiate studies designed to evaluate its new closure technology. The collagen matrix used in the technology has the potential to deliver and localise drugs and other materials that may...
Arena Pharmaceuticals has announced the latest results of a phase I clinical trial that is testing a novel insomnia compound, which could treat the 30 to 40 per cent of US adults, who complain about some level of insomnia in the course of a year, and...
The UK's figures on recycling waste is skewed because companies are exporting their problem rather than increasing reprocessing rates, the UK's second largest packaging waste compliance company claims.
A major food equipment manufacturer has announced plans to expand into pharmaceutical equipment and processing, following its purchase from Italian owners CIR last month.
US researchers have identified a specific pathway that causes inflammation in lung tissue, a discovery that could help in the design of more targeted drug treatments for patients with various lung diseases, including cystic fibrosis, reports Wai Lang...
The drug resistance encountered by scientists when treating cancer cells has been the subject of research by German scientists who believe they have identified a cellular protein, which mediates a death signal.
In-PharmaTechnologist.com reports its periodic round-up of personnel changes in pharmaceutical manufacturing and development.
Applied DNA Sciences has entered into collaboration with Advanced Coding Systems (ACS), in a deal to develop security products for brand protection and electronic article surveillance for pharmaceutical supply chain management.